Seda TOPÇU, Betül ULUKOL, Deniz SEZGİN EMÜLER, Hasan Onur TOPÇU, Gülsen CEYHUN PEKER, , Fulya DÖKMECİ, Sevgi BAŞKAN

Hekimlerin human papillomavirus enfeksiyonu ve aşısı ile ilgili farkındalıkları ve yaklaşımları

Amaç: Hekimlerin human papillomavirus (HPV) ile ilgili farkındalıkları ve HPV aşısının uygulanması konusundaki yaklaşımlarını değerlendirmek amaçlanmıştır.Gereç ve Yöntem: Araştırmaya 147 hekim (98 kadın doğum hekimi, 49 çocuk-aile hekimi dahil edilmiştir. Katılımcılara, araştırmacılar tarafından geliştirilen HPV enfeksiyonu ve HPV aşısı hakkında bilgi ve yaklaşımları değerlendirmek için hazırlanan bir anket formu uygulanmış ve toplanan veriler analiz edilmiştir.Bulgular: Araştırmaya dahil edilen kadın doğum hekimlerinin yaş ortalaması 28.2 yıl, çocuk-aile hekimlerinin 29.2 yıl olup her iki grupta da kadın cinsiyet ağırlıklıdır. Kadın doğum hekimlerinin %74’ü, çocuk hekimlerinin %71’i aşıyı kendilerine yaptırmayı düşündüğünü ifade etmiştir. Kadın doğum hekimlerinin %85’i, çocuk-aile hekimlerinin %78’i aşıyı önerdiklerini ifade etmişlerdir.Sonuç: Toplumda görülen serviks kanserine bağlı ölümler, çocuklara ve ailelere danışmanlık yapacak pozisyonda olan hekimlerin, HPV enfeksiyonu ve HPVaşısı konusunda bilgi düzeylerinin artırılmasıyla, aşının önerilme oranlarını artırarak önlenebilir.

Anahtar Kelimeler:

Human papilloma virüsü, hekimler, aşı

Physicians' awareness and approaches to human papillomavirus infection and vaccination

Purpose: To evaluate the awareness of human papillomavirus (HPV) infection and attitude of the vaccination of the medical doctors among HPV vaccination.Material and Methods: A total of 147 medical doctors (98 from the department of Obstetrics and Gynecology and 49 from the department of pediatrics) were enrolled into this study. A survey which measure the knowledge and attitude about HPV infection and vaccination received by the participants. Statistical analyses were performed to evaluate and compare the knowledge and attitude of the medical doctors.Results: The average ages of the Obstetrician and Gynecologists and pediatricians were 28.2 and 29.2; respectively. The rate of willingness of self-vaccination for HPV in Obstetrician and Gynecologists and Pediatrician groups were 74% and %71; respectively. The recommendation rates in Obstetrician and Gynecologists and Pediatrician groups were 85% and 78%; respectively.Conclusion: The mortality related cervix cancer may be decreased by increasing the awareness of HPV infection and HPV vaccination of the medical doctors who may recommend the HPV vaccine to the parents for their children.

Keywords:

Human papilloma virus, medical doctors, vaccine,

PDF

___

1. Pickering LK, Baker CJ, Long SS, McMillan JA. RedBook: 2006 Report of the Committee on Infectious Diseases. 27th ed. ElkGroveVillage, IL: American Academy of Pediatrics, 2006.
2. Munoz N, Bosch X, Castellsague X, Diaz M, Desanjose S, Hammouda D et al. Against which human papillomavırus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111:278-85.
3. Munoz N, Bosch X, Sanjosé X, Herrero R, Castellsagué X, Shah KV et al. The International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-27.
4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917.
5. Türkiye Halk Sağlığı Kurumu Kanser Daire Başkanlığı 2009 verileri http://kanser.gov.tr/Dosya/ca_istatistik/2009kanser raporu.pdf.
6. Ozcelik B, Serin IS, Gokahmetoglu S, Basbug M, Erez R. Human papillomavirus frequency of women at low risk of developing cervical cancer: a preliminary study from a Turkish university hospital. Eur J Gynaecol Oncol. 2003;24:157-9.
7. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-30.
8. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137-50.
9. Garnett GP, Kim JJ, French K, Goldie SJ. Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine. 2006;24:S3/178-86.
10. PollackAE, BalkinMB, Edouard L, Cutts F, Broutet NB Ensuring access to HPV vaccines through integrated services: a reproductive health perspective. Bull World Health Organ. 2007;85:57-63.
11. Human papillomaviruses. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015:576-83.
12. Seçkin S, Aksoy F, Yıldırım M. Servikal Smearlerde HPV infeksiyonu görülme indisansı. Ankara Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi. 1996;36:101-3.
13. Ozcelik B, Serin IS, Gokahmetoglu S, Basbug M, Erez R. Human papillomavirus frequency of women at low risk of developing cervical cancer: a preliminary study from a Turkish university hospital. Eur J Gynaecol Oncol. 2003;24:157-9.
14. Durusoy R, Yamazhan M, Taşbakan MI, Ergin I, Aysin M, Pullukçu H et al. HPV vaccine awareness and willingness of first-year students entering university in Western Turkey. Asian Pac J Cancer Prev. 2010;11:1695-701.
15. Sherman SM, Nailer E, Minshall C, Coombes R, Cooper J, Redman CW. Awareness and knowledge of HPV and cervical cancer in female students: A survey (with a cautionary note). J Obstet Gynaecol. 2015;25:1-5.
16. Hsu YY, Fetzer SJ, Hsu KF, Chang YY, Huang CP, Chou CY. Intention to obtain human papillomavirus vaccination among Taiwanese undergraduate women. Sex Transm Dis. 2009;36:686-92 .
17. Kang HS, Moneyham L. Attitudes toward and intention to receive the human papilloma virus (HPV) vaccination and intention to use condoms among female Korean college students. Vaccine. 2010;28:811-6.
18. American Academy of Pediatrics Committee on Infectious Diseases. HPV vaccine recommendations. Pediatrics. 2012;129:602-5.
19. Hershey JH, Velez LF. Public health issues related to HPV vaccination. J Public Health Manag Pract. 2009;15:384-92.
20. Downs LS Jr, Scarinci I, Einstein MH, Collins Y, Flowers L. Overcoming the barriers to HPV vaccination in high-risk populations in the US. Gynecol Oncol. 2010;117:486-490.
21. Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Hlth (Larchmt). 2009;18:1679-86.
22. Donders GG, Bellen G, Declerq A, Berger J, Van Den Bosch T, Riphagen I et al . Change in knowledge of women about cervix cancer, human papilloma virus (HPV) and HPV vaccination due to introduction of HPV vaccines. Eur J Obstet Gynecol Reprod Biol. 2009;145:93-5.
23. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168:76-82.
24. Dorell CG, Yankey D, Santibanez TA, Markwitz LE. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics. 2011;128: 830-9.